** Shares of medical equipment maker Bruker Corp BRKR.O up 0.5% at $29.50 premarket after it secured capital raise
** Massachusetts-based Bruker late Weds announced pricing $600 mln 6.375% mandatory convertible preferred stock offering
** Unless earlier converted by investors, preferred stock will automatically convert into a number of shares of BRKR common stock based on the avg volume-weighted price of the common stock over the 20 consecutive trading days preceding the conversion date of Sept 1, 2028
** Threshold appreciation price of $35.95 represents approx 22.5% premium over BRKR stock last sale
** BRKR stock on Weds tumbled 11.7% to $29.35 after co late Tues commenced the offering to strengthen its balance sheet by fully repaying term loan due Dec 2026, and other outstanding debt
** JP Morgan and BofA are joint bookrunners for the offering
** Through Weds close, shares have shed 50% in 2025 giving them about $4.5 bln market cap
** Avg rating among 14 analysts covering the shares is "buy" and median PT is $43, per LSEG
(Lance Tupper is a Reuters market analyst. The views expressed are his own)
((lance.tupper@tr.com 1-646-279-6380))